Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 4 de 4
Filtrar
Más filtros










Base de datos
Intervalo de año de publicación
1.
Actas Urol Esp ; 38(9): 622-7, 2014 Nov.
Artículo en Inglés, Español | MEDLINE | ID: mdl-24909334

RESUMEN

BACKGROUND: Teratomas are a spectrum of neoplasms that can undergo malignant transformation. In the World Health Organization (WHO) classification of tumors, this entity was classified as «teratoma with somatic-type malignancy¼, was defined as a malignant neoplasm of non-germinal phenotype that originates in a teratoma. MATERIALS AND METHODS: We present a serie of nine cases of testicular teratomas with secondary malignant transformation. From January 1995 to December 2011, we found a total of 306 cases of testicular tumors. Mixed germ cell tumors were the most frequently diagnosed malignancy with 45.7%. RESULTS: Teratoma with secondary malignant transformation, represented 2.9% of all germinal tumors. Five cases originated within a mixed germ cell tumor, two cases from mature teratomas, and two from immature teratomas. The predominante malignant somatic component were sarcomas; two cases of chondrosarcoma, one rhabdomyosarcoma, and one case showing foci of chondrosarcoma and rhabdomyosarcoma. The case of osteosarcoma is notable for its rarity. Two cases showed epithelial malignancy in the form of an adenocarcinoma, and finally, two cases were primitive neuroectodermal tumors. At the time of diagnosis, five patients had metastases. CONCLUSION: The transformation of germ cell tumors to somatic type malignancies is rare. The malignant component can originate from any of the three germ lines. These tumors are resistant to standard chemotherapy for a germ cell tumor and the clinical stage is the most important prognostic factor. At our institution, the malignant component that appeared most frequently was chondrosarcoma.


Asunto(s)
Transformación Celular Neoplásica , Teratoma/patología , Neoplasias Testiculares/patología , Adolescente , Adulto , Humanos , Masculino , Persona de Mediana Edad , Neoplasias de Células Germinales y Embrionarias/patología , Estudios Retrospectivos , Adulto Joven
2.
Cancer Gene Ther ; 20(11): 642-9, 2013 Nov.
Artículo en Inglés | MEDLINE | ID: mdl-24052127

RESUMEN

A phase I-II study to evaluate gene-mediated cytotoxic immunotherapy in newly diagnosed prostate cancer before radical prostatectomy was conducted in Monterrey, Mexico. First, to investigate delivery of adenovirus to the prostate, fluorescently labeled vector was injected into fresh prostatectomy specimens and distribution was visually analyzed. The optimal volume and site instillation was then used for transrectal ultrasound guided intraprostatic injection in 10 patients with adenocarcinoma scheduled for radical prostatectomy. Each received two apical and two basal 0.5 ml injections of AdV-tk for a total of 1 × 10(11) vp followed by 14 days of prodrug. Nine patients continued to tumor resection: six high risk, one intermediate and two low risk. In vivo vector distribution was analyzed from the resected tissue of four patients. Patients were monitored for tumor progression and acute and long-term safety. For vector delivery, two apical and two basal injections of 0.5 ml led to optimal organ-wide distribution ex vivo and in vivo. Cytotoxicity was evidenced by transient rise in PSA and tumor histology. There were no significant adverse events deemed related to the treatment and no late toxicities after median follow-up of 11.3 years. All six high-risk patients had positive surgical margins and one had seminal vesicle involvement. Despite slow PSA rise post surgery in three of these patients, none developed metastases. The intermediate- and low-risk patients had complete resections and none have progressed. In conclusion, in vivo transrectal ultrasound guided instillation of an adenoviral vector into four sites in the prostate was practical as an outpatient procedure, well tolerated and led to distribution throughout the intraprostatic tumor mass. AdV-tk demonstrated no significant acute or late toxicities. Trends in PSA and disease progression conveyed the possibility of a sustained immune response against residual disease.


Asunto(s)
Adenoviridae/fisiología , Viroterapia Oncolítica/métodos , Neoplasias de la Próstata/terapia , Adenoviridae/genética , Adenoviridae/inmunología , Anciano , Estudios de Seguimiento , Técnicas de Transferencia de Gen , Terapia Genética/métodos , Vectores Genéticos/genética , Vectores Genéticos/inmunología , Vectores Genéticos/farmacocinética , Humanos , Inmunoterapia/métodos , Calicreínas/metabolismo , Masculino , Persona de Mediana Edad , Terapia Neoadyuvante , Antígeno Prostático Específico/metabolismo , Neoplasias de la Próstata/genética , Neoplasias de la Próstata/cirugía , Neoplasias de la Próstata/virología , Simplexvirus/enzimología , Simplexvirus/genética , Timidina Quinasa/genética
3.
Int J Immunogenet ; 37(5): 355-9, 2010 Oct.
Artículo en Inglés | MEDLINE | ID: mdl-20518842

RESUMEN

The purpose of this study was to assess the role of Helicobacter pylori and several genetic polymorphisms in relation to inflammatory bowel disease (IBD). We studied 44 unrelated patients with IBD and 75 subjects with no history of IBD as controls. Using pyrosequencing technology, we identified gene polymorphisms in IL-10, TNF-A, ILB-31, and TLR4. H. pylori status was determined by serology. Individuals homozygous for IL10-592 A or IL10-1082 A genotypes show significantly lower occurrence of IBD (P=0.03 and P<0.01, respectively). Individuals heterozygous at IL10-1082 have significantly increased occurrence of IBD, both ulcerative colitis and Crohn's disease (P<0.01). There was no difference in the prevalence of H. pylori infection between cases and controls. This study provides evidence that variation in IL10 is correlated with IBD occurrence in this Mexican population.


Asunto(s)
Enfermedades Inflamatorias del Intestino/epidemiología , Enfermedades Inflamatorias del Intestino/genética , Adulto , Anciano , Colitis Ulcerosa/epidemiología , Colitis Ulcerosa/genética , Enfermedad de Crohn/epidemiología , Enfermedad de Crohn/genética , Femenino , Predisposición Genética a la Enfermedad , Haplotipos , Infecciones por Helicobacter/complicaciones , Helicobacter pylori , Humanos , Enfermedades Inflamatorias del Intestino/complicaciones , Interleucina-10/genética , Masculino , México/epidemiología , Persona de Mediana Edad , Polimorfismo de Nucleótido Simple , Factores de Riesgo , Adulto Joven
4.
Rev Gastroenterol Mex ; 74(4): 366-9, 2009.
Artículo en Español | MEDLINE | ID: mdl-20423770

RESUMEN

We report the case of a woman with peritoneal and gastric tuberculosis who presented with clinical and radiologic features mimicking an advanced gastric neoplasia. We emphasize the relevance of including tuberculosis in the differential diagnosis of patients with gastric wall thickness.


Asunto(s)
Carcinoma/diagnóstico , Neoplasias Peritoneales/diagnóstico , Peritonitis Tuberculosa/diagnóstico , Gastropatías/diagnóstico , Gastropatías/microbiología , Neoplasias Gástricas/diagnóstico , Tuberculosis Gastrointestinal/diagnóstico , Anciano , Diagnóstico Diferencial , Femenino , Humanos , Peritoneo
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA
...